Skip to Main Content

Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study

Conditions

Diabetes Mellitus - Type 2 | Diseases of the Endocrine System

What is the purpose of this trial?

This study is designed to test if there is a difference in brain glucose transport kinetics in poorly controlled T2DM individuals with short duration and long duration of diabetes, using non-invasive magnetic resonance spectroscopy (MRSI). Also, if these changes are reversible with improved glucose control will be tested. A better understanding of the impact of duration of diabetes on brain glucose transport function may have important implications for understanding the pathophysiology of brain complications in T2DM.

  • Trial with
    National Center for Advancing Translational Sciences (NCATS)
  • Start Date
    10/12/2021
  • End Date
    03/31/2022

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/03/2021
  • Study HIC
    #2000027293